In vivo effect of celecoxib and tenoxicam on oxidant/ anti-oxidant status of patients with knee osteoarthritis.
Salih Özgöçmen(Tokat Gaziosmanpaşa Üniversitesi), Huseyin Gudul, Özge Ardıçoğlu(Fırat University), Hasan Erdoğan(Tokat Gaziosmanpaşa Üniversitesi), Ersin Fadıllıoğlu(Inonu University)
PubMed
January 1, 2005
Cited by 44
Related Papers
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
|Annals of the Rheumatic Diseases|2017|1.6k
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
|Annals of the Rheumatic Diseases|2011|988
Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study
|Annals of the Rheumatic Diseases|2015|268
Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis
|Molecular and Cellular Biochemistry|2006|204
Protective effect of caffeic acid phenethyl ester (CAPE) administration on cisplatin‐induced oxidative damage to liver in rat
|Cell Biochemistry and Function|2006|147